A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma
Mark S. Talamonti(Northwestern University), Cornelius J. McGinn(University of Southern Maine), Philip A. Philip(Wayne State University), Jeffrey D. Wayne(Northwestern University), Vikram Attaluri(Northwestern University), William Small(Northwestern University), Mary F. Mulcahy(Northwestern University), Timothy J. Kinsella(University Hospitals of Cleveland), John P. Hoffman(Fox Chase Cancer Center), Gary M. Freedman(Fox Chase Cancer Center), Lisa M. Colletti(University of Michigan), Mark M. Zalupski(University of Michigan)
Cited by 237
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
|Journal of the National Comprehensive Cancer Network|2010|1.2k